Citation: | JIANG Tingting, LIU Dongsheng, CHEN Ying. Effect of senkyunolide I on cholestatic liver injury via the STAT3 signaling pathway[J]. Journal of Xuzhou Medical University, 2024, 44(12): 876-881. DOI: 10.12467/j.issn.2096-3882.20240683 |
[1] |
El-Agamy DS,Almaramhy HH,Ahmed N,et al.Anti-inflammatory effects of vardenafil against cholestatic liver damage in mice:a mechanistic study[J].Cell Physiol Biochem,2018,47(2):523-534.
|
[2] |
Watanabe S,Tsuneyama K.Eicosapentaenoic acid attenuates hepatic accumulation of cholesterol esters but aggravates liver injury and inflammation in mice fed a cholate-supplemented high-fat diet[J].J Toxicol Sci,2013,38(3):379-390.
|
[3] |
Colares JR,Hartmann RM,Schemitt EG,et al.Melatonin prevents oxidative stress,inflammatory activity,and DNA damage in cirrhotic rats[J].World J Gastroenterol,2022,28(3):348-364.
|
[4] |
冯帅霞,徐莹,韩涵,等.龙胆苦苷调控PPAR-α改善胆汁淤积性肝损伤的药效机制研究[J].上海中医药杂志,2024,58(2):84-91.
|
[5] |
Yang Q,Zhao ZZ,Xie J,et al.Senkyunolide I attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative,anti-inflammatory and anti-apoptotic pathways[J].Int Immunopharmacol,2021,97:107717.
|
[6] |
Zhang LZ,Hu YH,Qi SL,et al.Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease[J].Front Pharmacol,2022,13:965914.
|
[7] |
Hasegawa S,Yoneda M,Kurita Y,et al.Cholestatic liver disease:current treatment strategies and new therapeutic agents[J].Drugs,2021,81(10):1181-1192.
|
[8] |
Brevini T,Tysoe OC,Sampaziotis F.Tissue engineering of the biliary tract and modelling of cholestatic disorders[J].J Hepatol,2020,73(4):918-932.
|
[9] |
Tao WL,Yue X,Ye RL,et al.Hepatoprotective effect of the Penthorum chinense pursh extract against the CCl4-induced acute liver injury via NF-κB and p38-MAPK PATHWAYS in dogs[J].Animals (Basel),2022,12(5):569.
|
[10] |
Jones BE,Lo CR,Liu H,et al.Role of caspases and NF-kappaB signaling in hydrogen peroxide- and superoxide-induced hepatocyte apoptosis[J].Am J Physiol Gastrointest Liver Physiol,2000,278(5):G693-G699.
|
[11] |
Cederbaum AI,Lu YK,Wu DF.Role of oxidative stress in alcohol-induced liver injury[J].Arch Toxicol,2009,83(6):519-548.
|
[12] |
Kasembeli MM,Bharadwaj U,Robinson P,et al.Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment[J].Int J Mol Sci,2018,19(8):2299.
|
[13] |
Yu HM,Zhi JL,Cui Y,et al.Role of the JAK-STAT pathway in protection of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress in PC12 cells[J].Apoptosis,2006,11(6):931-941.
|
[14] |
Butturini E,de Prati AC,Mariotto S.Redox regulation of STAT1 and STAT3 signaling[J].Int J Mol Sci,2020,21(19):7034.
|
[15] |
Qu Y,Oyan AM,Liu RH,et al.Generation of prostate tumor-initiating cells is associated with elevation of reactive oxygen species and IL-6/STAT3 signaling[J].Cancer Res,2013,73(23):7090-7100.
|
[16] |
Waris G,Huh KW,Siddiqui A.Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress[J].Mol Cell Biol,2001,21(22):7721-7730.
|
[17] |
Wang BE.Treatment of chronic liver diseases with traditional Chinesemedicine[J].J Gastroenterol Hepatol,2000,15 (Suppl):E67-E70.
|